tiprankstipranks
Trending News
More News >
ALK-abello A/S Class B (AKBLF)
OTHER OTC:AKBLF
Advertisement

ALK-abello (AKBLF) Similar Stocks

Compare
13 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ALK-abello
$35.72
$8.02B
48.43
56.14%
0 Buy
0 Hold
0 Sell
Moderate Buy
Dynavax
$11.43
$1.34B
-11.46%
3 Buy
0 Hold
0 Sell
Strong Buy
Inovio Pharmaceuticals
$1.96
$134.66M
-54.63%
2 Buy
1 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$2.88
$255.66M
-1.72
-29.24%
5 Buy
0 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$11.05
$580.35M
8.54
9.30%
1 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$130.44
$248.86B
17.66
27.06%
0 Buy
2 Hold
1 Sell
Moderate Sell
Bristol-Myers Squibb
$49.25
$100.26B
16.63
-12.71%
6 Buy
11 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBLF
ALK-abello
35.72
12.84
56.12%
DVAX
Dynavax
11.43
-1.43
-11.12%
INO
Inovio Pharmaceuticals
1.96
-2.36
-54.63%
ACRS
Aclaris Therapeutics
2.88
-1.19
-29.24%
EBS
Emergent Biosolutions
11.05
0.93
9.19%
NVS
Novartis
130.44
27.78
27.06%
BMY
Bristol-Myers Squibb
49.25
-7.17
-12.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis